60 related articles for article (PubMed ID: 10533981)
1. Use of bioluminescent aequorin for the pharmacological characterization of 5HT receptors.
Schaeffer MT; Cully D; Chou M; Liu J; Van der Ploeg LH; Fong TM
J Recept Signal Transduct Res; 1999 Nov; 19(6):927-38. PubMed ID: 10533981
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput glow-type aequorin assay for measuring receptor-mediated changes in intracellular calcium levels.
George SE; Schaeffer MT; Cully D; Beer MS; McAllister G
Anal Biochem; 2000 Nov; 286(2):231-7. PubMed ID: 11067745
[TBL] [Abstract][Full Text] [Related]
3. Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
Walstab J; Combrink S; Brüss M; Göthert M; Niesler B; Bönisch H
Anal Biochem; 2007 Sep; 368(2):185-92. PubMed ID: 17617370
[TBL] [Abstract][Full Text] [Related]
4. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors.
Ungrin MD; Singh LM; Stocco R; Sas DE; Abramovitz M
Anal Biochem; 1999 Jul; 272(1):34-42. PubMed ID: 10405290
[TBL] [Abstract][Full Text] [Related]
5. Measurement of intracellular calcium using bioluminescent aequorin expressed in human cells.
Sheu YA; Kricka LJ; Pritchett DB
Anal Biochem; 1993 Mar; 209(2):343-7. PubMed ID: 8470808
[TBL] [Abstract][Full Text] [Related]
6. Novel agonists of 5HT2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-1-methylethylamines and 2-(indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved therapeutics for obsessive compulsive disorder.
Bös M; Jenck F; Martin JR; Moreau JL; Sleight AJ; Wichmann J; Widmer U
J Med Chem; 1997 Aug; 40(17):2762-9. PubMed ID: 9276022
[TBL] [Abstract][Full Text] [Related]
7. Recombinant aequorin as a reporter for receptor-mediated changes of intracellular Ca2+ -levels in Drosophila S2 cells.
Torfs H; Poels J; Detheux M; Dupriez V; Van Loy T; Vercammen L; Vassart G; Parmentier M; Vanden Broeck J
Invert Neurosci; 2002 Apr; 4(3):119-24. PubMed ID: 12488971
[TBL] [Abstract][Full Text] [Related]
8. Detection of intracellular calcium elevations in Xenopus laevis oocytes: aequorin luminescence versus electrophysiology.
Grygorczyk R; Feighner SD; Adam M; Liu KK; LeCouter JE; Dashkevicz MP; Hreniuk DL; Rydberg EH; Arena JP
J Neurosci Methods; 1996 Jul; 67(1):19-25. PubMed ID: 8844521
[TBL] [Abstract][Full Text] [Related]
9. [Serotonin receptors (results of the pharmacological study)].
Valeeva LA; Sergeev PV; Shimanovskiĭ NL
Eksp Klin Farmakol; 1997; 60(6):57-61. PubMed ID: 9460603
[TBL] [Abstract][Full Text] [Related]
10. Mu-opioid receptor ligands lack receptor subtype selectivity in the aequorin luminescence-based calcium assay.
Fichna J; Staniszewska R; Poels J; Vanden Broeck J; Janecka A
Chem Biol Drug Des; 2007 Sep; 70(3):247-53. PubMed ID: 17718719
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-activated signal transduction via serotonin receptors on Jurkat cells.
Aune TM; Kelley KA; Ranges GE; Bombara MP
J Immunol; 1990 Sep; 145(6):1826-31. PubMed ID: 2144010
[TBL] [Abstract][Full Text] [Related]
12. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
Wesołowska A
Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
[TBL] [Abstract][Full Text] [Related]
13. Hormone-defined cell system for studying G-protein coupled receptor agonist-activated growth modulation: delta-opioid and serotonin-5HT2C receptor activation show opposite mitogenic effects.
Agarwal D; Glasel JA
J Cell Physiol; 1997 Apr; 171(1):61-74. PubMed ID: 9119893
[TBL] [Abstract][Full Text] [Related]
14. 5-Hydroxytryptamine type 2A and 2C receptors linked to Na+/K+/Cl- cotransport.
Mayer SE; Sanders-Bush E
Mol Pharmacol; 1994 May; 45(5):991-6. PubMed ID: 8190114
[TBL] [Abstract][Full Text] [Related]
15. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
Gannon RL; Millan MJ
Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
[TBL] [Abstract][Full Text] [Related]
16. Stable expression of a synthetic gene for the human motilin receptor: use in an aequorin-based receptor activation assay.
Carreras CW; Siani MA; Santi DV; Dillon SB
Anal Biochem; 2002 Jan; 300(2):146-51. PubMed ID: 11779105
[TBL] [Abstract][Full Text] [Related]
17. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
[TBL] [Abstract][Full Text] [Related]
18. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
19. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors.
Walstab J; Hammer C; Bönisch H; Rappold G; Niesler B
Pharmacogenet Genomics; 2008 Sep; 18(9):793-802. PubMed ID: 18698232
[TBL] [Abstract][Full Text] [Related]
20. Differential ion current activation by human 5-HT(1A) receptors in Xenopus oocytes: evidence for agonist-directed trafficking of receptor signalling.
Heusler P; Pauwels PJ; Wurch T; Newman-Tancredi A; Tytgat J; Colpaert FC; Cussac D
Neuropharmacology; 2005 Dec; 49(7):963-76. PubMed ID: 15964603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
